The influence of cisplatin, doxorubicin, pegylated doxorubicin, oxaliplatin and gemcitabine on mahlavu cell line

Sadeleştirilmiş öğe sayfası
dc.contributor.authorIlikhan, Sevil Uygun
dc.contributor.authorBilici, Muammer
dc.contributor.authorSahin, Hatice
dc.contributor.authorAkca, Ayse Semra Demir
dc.contributor.authorEngin, Huseyin
dc.contributor.authorBilir, Cemil
dc.contributor.authorSevinc, Nergis
dc.contributor.authorPelit, Nil Banu
dc.contributor.authorTekin, Ishak Ozel
dc.date.accessioned2025-10-16T15:31:30Z
dc.date.issued2015
dc.identifier.otherWOS:000354756500034
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9030
dc.publisherZERBINIS MEDICAL PUBL
dc.sourceJOURNAL OF BUON
dc.subjectcell death
dc.subjectchemotherapy
dc.subjecthepatocellular carcinoma
dc.subjectmahlavu cell line
dc.titleThe influence of cisplatin, doxorubicin, pegylated doxorubicin, oxaliplatin and gemcitabine on mahlavu cell line
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS